.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Novartis
Teva
Moodys
Julphar
Chubb
Fuji
Colorcon
Fish and Richardson

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020963

« Back to Dashboard
NDA 020963 describes TIMOLOL MALEATE, which is a drug marketed by Usl Pharma, Apotex Inc, Akorn, Watson Labs, Pacific Pharma, Teva, Sandoz, Fdc Ltd, Sandoz Inc, Hi Tech Pharma, Quantum Pharmics, Fougera, Mylan, Wockhardt, and Bausch And Lomb, and is included in thirty-eight NDAs. It is available from sixteen suppliers. There is one patent protecting this drug. Additional details are available on the TIMOLOL MALEATE profile page.

The generic ingredient in TIMOLOL MALEATE is timolol maleate. There are fifteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.

Summary for 020963

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020963

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 020963

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TIMOLOL MALEATE
timolol maleate
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC 020963 NDA Sandoz Inc 61314-224 61314-224-05 5 mL in 1 BOTTLE (61314-224-05)
TIMOLOL MALEATE
timolol maleate
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC 020963 NDA Sandoz Inc 61314-224 61314-224-25 2.5 mL in 1 BOTTLE (61314-224-25)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION, GEL FORMING/DROPS;OPHTHALMICStrengthEQ 0.25% BASE
Approval Date:Oct 21, 1998TE:ABRLD:No
Patent:► SubscribePatent Expiration:Sep 26, 2019Product Flag?Substance Flag?Delist Request?Y

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION, GEL FORMING/DROPS;OPHTHALMICStrengthEQ 0.5% BASE
Approval Date:Oct 21, 1998TE:ABRLD:No
Patent:► SubscribePatent Expiration:Sep 26, 2019Product Flag?Substance Flag?Delist Request?Y


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
US Department of Justice
Citi
Colorcon
Dow
Mallinckrodt
AstraZeneca
Queensland Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot